Unknown

Dataset Information

0

Live Virus Neutralisation of the 501Y.V1 and 501Y.V2 SARS-CoV-2 Variants following INO-4800 Vaccination of Ferrets.


ABSTRACT: The ongoing COVID-19 pandemic has resulted in significant global morbidity and mortality on a scale similar to the influenza pandemic of 1918. Over the course of the last few months, a number of SARS-CoV-2 variants have been identified against which vaccine-induced immune responses may be less effective. These "variants-of-concern" have garnered significant attention in the media, with discussion around their impact on the future of the pandemic and the ability of leading COVID-19 vaccines to protect against them effectively. To address concerns about emerging SARS-CoV-2 variants affecting vaccine-induced immunity, we investigated the neutralisation of representative 'G614', '501Y.V1' and '501Y.V2' virus isolates using sera from ferrets that had received prime-boost doses of the DNA vaccine, INO-4800. Neutralisation titres against G614 and 501Y.V1 were comparable, but titres against the 501Y.V2 variant were approximately 4-fold lower, similar to results reported with other nucleic acid vaccines and supported by in silico biomolecular modelling. The results confirm that the vaccine-induced neutralising antibodies generated by INO-4800 remain effective against current variants-of-concern, albeit with lower neutralisation titres against 501Y.V2 similar to other leading nucleic acid-based vaccines.

SUBMITTER: Riddell S 

PROVIDER: S-EPMC8269317 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC8977452 | biostudies-literature
| S-EPMC8516974 | biostudies-literature
| S-EPMC8330769 | biostudies-literature
| S-EPMC8153447 | biostudies-literature
| S-EPMC8043583 | biostudies-literature
| S-EPMC8644048 | biostudies-literature
| S-EPMC8639073 | biostudies-literature
| S-EPMC9302940 | biostudies-literature
| S-EPMC5627269 | biostudies-literature
| S-EPMC7759123 | biostudies-literature